Home › Funds › TWO SIGMA ADVISERS, LP › IONS

TWO SIGMA ADVISERS, LP position in IONS

IONIS PHARMACEUTICALS INC · Health Care

TWO SIGMA ADVISERS, LP reported holding 3,052,111 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q4 2025 13F filing — a position valued at US$241.5M, representing 0.47% of its reported portfolio and ranking #47 among its reported holdings. TWO SIGMA ADVISERS, LP has disclosed IONS holdings in 10 of the last 10 reported quarters, going back to Q3 2023.

Latest position (Q4 2025)3.05M sh
Reported value held$241.45M
Portfolio Weight0.47%
First reportedQ3 2023
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How TWO SIGMA ADVISERS, LP's IONS position evolved

TWO SIGMA ADVISERS, LP first disclosed a stake in IONS in Q3 2023 at 604,311 shares (US$27.4M). The position peaked in Q4 2025 at 3,052,111 shares, worth US$241.5M. Across 10 filings, TWO SIGMA ADVISERS, LP increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q4 2025) shows 3,052,111 shares valued at US$241.5M — an increase of 979,000 shares quarter over quarter.. Notable position changes include a 34% increase in Q1 2024 (shares rose 10% over the following quarter), a 55% increase in Q1 2025 (shares rose 31% over the following quarter), a 47% increase in Q4 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 604.31K $27.41M New
Q4 2023 777.01K $39.31M Add
Q1 2024 1.04M $45.09M Add
Q2 2024 1.29M $61.34M Add
Q3 2024 1.33M $53.38M Add
Q4 2024 1.35M $47.17M Add
Q1 2025 2.09M $63.12M Add
Q2 2025 2.67M $105.40M Add
Q3 2025 2.07M $135.62M Reduce
Q4 2025 3.05M $241.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), Tweedy, Browne Co LLC (US$180.8M), Deep Track Capital, LP (US$174.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has TWO SIGMA ADVISERS, LP held IONS?

TWO SIGMA ADVISERS, LP has disclosed IONS holdings in 10 of the last 10 reported quarters, going back to Q3 2023.

What is TWO SIGMA ADVISERS, LP's current position in IONS?

As of Q4 2025, TWO SIGMA ADVISERS, LP holds 3.05M shares of IONS (IONIS PHARMACEUTICALS INC), valued at $241.45M, representing 0.47% of its reported portfolio and ranking #47.

Has TWO SIGMA ADVISERS, LP been buying or selling IONS?

In the latest 13F filing (Q4 2025), TWO SIGMA ADVISERS, LP increased its position in IONS. The position peaked in Q4 2025 at 3.05M shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, Tweedy, Browne Co LLC, Deep Track Capital, LP, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.